Results 81 to 90 of about 1,492,137 (202)

Japanese Encephalitis (JE) Vaccine Workgroup [PDF]

01-JE-Vaccine-Bocchini ...

core  

Japanese Encephalitis Vaccine Work Group update [PDF]

JE-vaccine-Bocchini ...

core  

Dengue Associated Acute Encephalitis Syndrome Cases in Son La Province, Vietnam in 2014 [PDF]

, 2017
Acute encephalitis syndrome (AES) is associated with high morbidity and mortality, and affects both children and adults. The main etiologic agent is Japanese encephalitis virus (JEV); however, there are also reports of Dengue virus (DENV) encephalitis ...
Thi, Thu Thuy Nguyen, Thi, Hien Thu Le, Thi Hien Thu, Le, Moi, Meng Ling, Thi Thu Thuy, Nguyen, Morita, Kouichi, Muthugala, Rohitha V., Ngwe, Tun Mya Myat, Viet, Hoang Nguyen, Thi, Quynh Mai Le, Ngwe Tun, Mya Myat, Thi, Dinh Dang, Hoai, Linh Ly Pham, Buerano, Corazon C., Viet Hoang, Nguyen, Hasebe, Futoshi, Hoai Linh Ly, Pham, Thi Dinh, Dang, Thi Quynh Mai, Le   +18 more
core   +1 more source

Epidemiological trends and characteristics of Japanese encephalitis changed based on the vaccination program between 1960 and 2013 in Guangxi Zhuang Autonomous Region, southern China

International Journal of Infectious Diseases, 2016
Japanese encephalitis (JE) is one of the most severe kinds of viral encephalitis and is prevalent in Asia and the Western Pacific. In China, JE was first reported in the 1940s and became the main cause of viral encephalitis, including in the Guangxi ...
Yan Yang, Nengxiu Liang, Yi Tan, Zhichun Xie   +3 more
doaj   +1 more source

Japanese Encephalitis Vaccines; Recommendations of the Advisory Committee on Immunization Practices (ACIP) [PDF]

"This report updates the 1993 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the prevention of Japanese encephalitis (JE) among travelers (CDC.

core  

Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.

PLoS Neglected Tropical Diseases, 2019
Genotype III (GIII) Japanese encephalitis virus (JEV) predominance has gradually been replaced by genotype I (GI) over the last 20 years in many Asian countries.
Jianchao Wei, Xin Wang, Junjie Zhang, Shuang Guo, Linlin Pang, Kun Shi, Ke Liu, Donghua Shao, Yafeng Qiu, Lihong Liu, Frederik Widén, Beibei Li, Zhiyong Ma   +12 more
doaj   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

010602

ACIP Japanese Encephalitis (JE) and Yellow Fever (YF) Vaccines Work Group / Joseph A. Bocchini -- Background of YF disease, YF vaccine, andrecent vaccine developments / J.

core  

Epidemiology of Japanese encephalitis: past, present, and future prospects

, 2015
Huanyu Wang,1,2 Guodong Liang1,21State Key Laboratory for Infectious Disease Prevention and Control (SKLID), Department of Viral Encephalitis, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention ...
Liang G, Wang H
core  

Investigating Nonspecific Effects of the Live-Attenuated Japanese Encephalitis Vaccine on Lower Respiratory Tract Infections in Children Aged 25-35 Months: Retrospective Cohort Study

JMIR Public Health and Surveillance
BackgroundLive attenuated vaccines may be used to prevent nontargeted diseases such as lower respiratory tract infections (LRTIs) due to their nonspecific effects (NSEs).
Siyi Zhan, Hongbo Lin, Yingying Yang, Tao Chen, Sheng Mao, Chuanxi Fu   +5 more
doaj   +1 more source